Multiple new products establish new levels of radiology automation, efficiency and productivity -- and drive customer interest

Boston, MA, March 1, 2007 /PRNewswire/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today announced that 18 new contracts were signed in the fourth quarter of 2006 which shows continued market penetration into hospitals and ambulatory imaging businesses with the acclaimed Vision Series suite of products.

The 18 contracts include a mix of eight new hospitals or hospital groups and ten ambulatory customers that include imaging centers, teleradiology businesses, and radiology groups. The new hospital contracts include three new hospitals with a MEDITECH™ hospital information system. Several of the new ambulatory contracts include multiple AMICAS product lines and there were a number of additional products ordered by existing customers.

"We believe our products and services continue to deliver tremendous value to our customers," said Paul Merrild, AMICAS vice president of marketing. "In the fourth quarter of 2006, we were very pleased to see improved execution on our sales and marketing strategies, which highlight differentiating value to help customers grow, run and optimize their radiology operations."

AMICAS offers a best-in-class image management platform for hospitals and an integrated RIS, PACS, document management, and revenue cycle management solution for ambulatory imaging businesses.

Peter McClennen, president and chief operating officer of AMICAS said, “We have and will continue to invest significantly in R&D and customer service programs focused on the radiology market. The new products we recently introduced that are now being delivered to customers appear to be very attractive in the market.”

At the RSNA tradeshow in November of 2006, AMICAS launched multiple new innovations including Vision Series PACS 5.0, Vision Reach, and Insight Services. All of these new products are now live at client facilities with PACS 5.0 and Vision Reach generally available to the market. RadStream was also introduced at RSNA. This revolutionary workflow tool was recently acquired by AMICAS and demonstrates a level of workflow automation that we believe is unique in the marketplace.

“We are very excited about the energy and enthusiasm with which the market is responding to our most recent new product introductions,” said Mr. Merrild. “The buzz around our innovations such as RadStream and Vision Reach started in earnest at the RSNA tradeshow and is continuing strong in the market today.”

AMICAS, Vision Series, RadStream, Vision Reach and Insight Services are trademarks or registered trademarks of AMICAS, Inc. All other company and trademark names are the property of their respective owners.

About AMICAS, Inc.
AMICAS, Inc. (www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS® Vision Series™ products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight™ Solutions, a set of client-centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise. HIS and RIS mean hospital information system and radiology information system, respectively.

Safe Harbor Statement
Except for the historical information herein, the matters discussed in this release include forward-looking statements. The forward-looking statements contained in this release include statements about present and future product and service availability, performance and implementation. When used in this press release, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause actual results to differ materially as set forth in AMICAS' most recent filings with the Securities and Exchange Commission. All forward-looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release.